Concepedia

Extended-release Dosage Forms

Extended-Release Dosage Forms is a pharmaceutical formulation designed to release the incorporated drug over an extended period of time following its administration, thereby maintaining therapeutic plasma concentrations for prolonged durations compared to immediate-release counterparts.

279

Publications

12.8K

Citations

1.1K

Authors

402

Institutions

Publications per year

2017–2026

34

Variants

Extended-release Formulations

Parents

Publications

279

Stereolithographic (SLA) 3D printing of oral modified-release dosage forms

Jie Wang, Álvaro Goyanes, Simon Gaisford et al. · International Journal of Pharmaceutics · 2016 · 597 citations · Full text

, , +12

Mucoadhesive drug delivery system: An overview

BinduM Boddupalli, ZulkarN.K Mohammed, RavinderA Nath et al. · Journal of Advanced Pharmaceutical Technology amp Research · 2010 · 527 citations · Full text

, , +13

Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

GT Tucker, Clare E. Casey, PJ Phillips et al. · British Journal of Clinical Pharmacology · 1981 · 495 citations · Full text

, , +17

A flexible-dose dispenser for immediate and extended release 3D printed tablets

Katarzyna Pietrzak, Abdullah Isreb, Mohamed A. Alhnan · European Journal of Pharmaceutics and Biopharmaceutics · 2015 · 406 citations · Full text

, , +14

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study

Michael Davidson, Robin Emsley, Michelle Kramer et al. · Schizophrenia Research · 2007 · 252 citations

, , +13

1–5 of 279

Authors

1.1K

  1. GL
    Gordon L. Amidon

    University of Michigan, United States

    6 publications · 403 citations

    6

    h-index

  2. PM
    Patrick Marroum

    AbbVie (United States), United States

    4 publications · 233 citations

    4

    h-index

  3. TW
    Torsten Wagner

    FH Aachen, Germany

    4 publications · 204 citations

    4

    h-index

  4. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    4 publications · 341 citations

    4

    h-index

  5. HK
    H. Kranz

    Freie Universität Berlin, Germany

    4 publications · 204 citations

    4

    h-index

1–5 of 1.1K

Institutions

402

  1. University of Michigan

    Ann Arbor, United States

    7 h-index

    13 publications

    527 citations

  2. Abbott Fund

    Chicago, United States

    6 h-index

    23 publications

    904 citations

  3. Bristol-Myers Squibb (United States)

    New York, United States

    6 h-index

    25 publications

    914 citations

  4. University of California, San Francisco

    San Francisco, United States

    5 h-index

    6 publications

    491 citations

  5. Novartis (Switzerland)

    Basel, Switzerland

    5 h-index

    11 publications

    577 citations

  6. Johnson & Johnson (United States)

    New Brunswick, United States

    5 h-index

    13 publications

    1.9K citations

  7. University of Wisconsin–Madison

    Madison, United States

    4 h-index

    5 publications

    180 citations

  8. Massachusetts General Hospital

    Boston, United States

    4 h-index

    4 publications

    458 citations

1–8 of 402

Venues

  1. International Journal of Pharmaceutics

    20 publications · 1.2K citations

    15

    h-index

  2. Clinical Therapeutics

    13 publications · 347 citations

    11

    h-index

  3. Journal of Pharmaceutical Sciences

    11 publications · 442 citations

    10

    h-index

  4. Pharmaceutical Research

    10 publications · 482 citations

    10

    h-index

  5. PubMed

    Repository · 12 publications · 321 citations

    10

    h-index

1–5